Sustained Benefits of Infliximab Therapy for Dermatologic and Articular Manifestations of Psoriatic Arthritis: Results From the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
Antoni, Christian E. MD 1; Kavanaugh, Arthur MD 2; Kirkham, Bruce MD 3; Tutuncu, Zuhre MD 2; Burmester, Gerd R. MD 4; Schneider, Udo MD 4; Furst, Daniel E. MD 5; Molitor, Jerry MD, PhD 6; Keystone, Edward MD 7; Gladman, Dafna MD, FRCPC 7; Manger, Bernhard MD 1; Wassenberg, Siegfried MD 8; Weier, Ralf MD 8; Wallace, Daniel J. MD 9; Weisman, Michael H. MD 9; Kalden, Joachim R. MD 1; Smolen, Josef MD 10
Arthritis & Rheumatism.
52(4):1227-1236, April 2005.
(Format: HTML, PDF)